Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNA, U6 small nuclear 900, pseudogene (abbreviated RNU6-900P) is a genomic sequence in humans officially recognized as a pseudogene—a non-functional copy or derivative of a gene that typically does not code for a functional product[13][9][5][1][11]. RNU6-900P is a variant of the U6 small nuclear RNA gene family, which normally participates in pre-mRNA splicing as part of the spliceosome, but as a pseudogene, it does not appear to produce functional RNA and has no documented biological, molecular, or pathological role[1][13][9]. It is annotated in gene databases (HGNC:47863; Ensembl ENSG00000207227) but is not listed as a therapeutic, diagnostic, or research target[13][7][5][11].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, U6 small nuclear 900, pseudogene (RNU6-900P).